| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Acumen Pharmaceuticals, Inc. | Director | Common Stock | 19,050 | $20,955 | $1.10 | 04 Jun 2025 | Direct |
| Acumen Pharmaceuticals, Inc. | Director | Stock Option (right to buy) | 19,500 | 04 Jun 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| ABOS | Acumen Pharmaceuticals, Inc. | 04 Jun 2025 | 2 | $0 | 4 | Director | 05 Jun 2025, 16:57 |
| ABOS | Acumen Pharmaceuticals, Inc. | 10 Jun 2024 | 1 | $0 | 4 | Director | 10 Jun 2024, 16:41 |
| ABOS | Acumen Pharmaceuticals, Inc. | 06 Jun 2023 | 1 | $0 | 4 | Director | 07 Jun 2023, 17:42 |
| ABOS | Acumen Pharmaceuticals, Inc. | 15 Jun 2022 | 1 | $0 | 4 | Director | 17 Jun 2022, 16:27 |
| ABOS | Acumen Pharmaceuticals, Inc. | 06 Jul 2021 | 1 | +$100,000 | 4 | Director | 08 Jul 2021, 18:13 |
| ABOS | Acumen Pharmaceuticals, Inc. | 30 Jun 2021 | 1 | $0 | 4 | Director | 02 Jul 2021, 16:17 |
| ABOS | Acumen Pharmaceuticals, Inc. | 30 Jun 2021 | 0 | $0 | 3 | Director | 30 Jun 2021, 19:10 |